The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Abzyme Therapeutics
Royersford, United States
B
11-50 Employees
2010
Key takeaway
Abzyme is actively seeking strategic collaborations to enhance antibody development, highlighting its capability to create a wide range of bispecific products through its innovative single-domain antibody generation platform.
Highlighted product
Product
Abz2 bispecific platform
Abpro
Woburn, United States
B
11-50 Employees
2007
Key takeaway
Abpro Corporation is developing a pipeline of T-cell engagers utilizing a tetravalent bispecific (TetraBi) format, which enhances efficacy and safety by optimizing antibody product formats. This innovative approach positions Abpro at the forefront of next-generation antibody therapies.
Highlighted product
Product
Technology – Abpro Corporation
Xencor
Monrovia, United States
B
51-100 Employees
1997
Key takeaway
Xencor specializes in the development of bispecific antibodies through its innovative XmAb technology, which allows for the rapid creation of differentiated antibody drug candidates by modifying Fc domains. This approach enhances the efficacy and half-life of antibodies, making Xencor a key player in advancing bispecific antibody therapies.
Highlighted product
Product
Bispecific Fc Domains | Xencor
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
Ab Studio
Hayward, United States
B
11-50 Employees
2017
Key takeaway
The company is a biotech startup dedicated to developing novel therapeutic antibodies, including bispecific and trispecific antibodies, aimed at treating challenging diseases such as cancer and infectious diseases. They utilize computer-aided antibody design to enhance the efficacy, safety, and manufacturability of these complex antibodies.
Highlighted product
Core business
AB Studio - Antibody Technology Platform, Bispecific & Trispecific Antibodies
AB Studio is a biotech startup focused on developing novel therapeutic antibodies to target difficult to treat diseases via computer-aided design.
AlivaMab Discovery Services
San Diego, United States
B
11-50 Employees
-
Key takeaway
AlivaMab Biologics (AMB) specializes in antibody discovery, offering advanced capabilities in developing bispecific antibodies and other multispecific formats. Their approach ensures rapid delivery of diverse, fully human antibodies, enhancing the success of drug development programs.
Highlighted product
Product
Technologies AlivaMab Discovery Services Superior Antibody Therapeutics
Adimab
Lebanon, United States
B
101-250 Employees
2007
Key takeaway
Adimab specializes in bispecific antibodies, offering a variety of formats that enhance biological functionality, which can significantly benefit scientists in discovering and optimizing therapeutic leads. Their comprehensive Adimab Platform integrates in vitro and in vivo methods, streamlining the workflow for effective lead development.
Highlighted product
Product
Technology | Adimab
Premier Human Antibody Discovery and Optimization
Soteria Biotherapeutics
San Francisco, United States
B
11-50 Employees
2018
Key takeaway
Soteria Biotherapeutics is focused on developing advanced bispecific T-cell engagers to effectively treat solid tumor cancers. Their innovative T-LITE™ platform enhances the safety and efficacy of bispecific antibody therapies, aiming to leverage the body's immune system to combat cancer.
Highlighted product
Product
Technology - Soteria BioTherapeutics
Technology overview Bispecific antibodies function by recognizing and binding to two different targets. In the case of T-cell engagers, one part of the bispecific binds to the T-cell and another to a target on the tumor cell (tumor antigen) with the goal of activating the T-cell against the tumor cell. Bispecific T-cell engagers have shown...
Creative-Biolabs
Shirley, United States
B
51-100 Employees
2005
Key takeaway
Creative Biolabs specializes in antibody development, offering comprehensive solutions that include monoclonal antibody production and advanced techniques like humanization and affinity maturation. Their expertise in phage display technology and extensive experience in preclinical drug discovery position them as a key player in the antibody engineering field.
Highlighted product
Core business
Creative Biolabs - Specialized in providing custom biotechnology and pharmaceutical services
Abterra Biosciences
San Diego, United States
B
1-10 Employees
2009
Key takeaway
Abterra Biosciences specializes in innovative antibody sequencing and discovery solutions, leveraging next-generation sequencing to enhance B-cell receptor sequencing and antibody therapeutics development. Their expertise in antibody discovery, including techniques like phage display, positions them as a key player in the field of bispecific antibodies.
Highlighted product
Core business
Abterra Biosciences | Antibody Discovery & Sequencing
Forbius
Austin, United States
B
11-50 Employees
2011
Key takeaway
Forbius is a protein engineering company that designs biotherapeutics, including monoclonal antibodies, to address diseases with unmet needs. They utilize innovative technologies such as receptor ectodomain-based traps and antibody-drug conjugates, which are relevant to the development of bispecific antibodies.
Highlighted product
Core business
Forbius
Technologies which have been searched by others and may be interesting for you:
In the Bispecific Antibody industry in the United States, several key considerations are critical for potential entrants and investors. Regulatory compliance is paramount, as the FDA oversees the approval process for new therapeutics, necessitating thorough understanding of clinical trial requirements and post-market surveillance. The competitive landscape is evolving rapidly, with numerous biotech firms and established pharmaceutical companies vying for market share. Researching the technological advancements in bispecific antibodies, such as novel engineering techniques and delivery methods, can reveal significant opportunities for innovation. Challenges in manufacturing and scale-up processes also warrant attention, as these can impact product viability and market entry timelines. Additionally, the industry's focus on personalized medicine creates a growing demand for bispecific antibodies that can target specific patient populations, enhancing treatment efficacy. Environmental considerations are increasingly relevant, particularly concerning sustainable practices in production and waste management. Finally, understanding the global market relevance, including collaborations and partnerships with international firms, can provide insights into potential growth avenues and competitive advantages in this dynamic sector.
Some interesting numbers and facts about your company results for Bispecific Antibody
| Country with most fitting companies | United States |
| Amount of fitting manufacturers | 1550 |
| Amount of suitable service providers | 925 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 1997 |
| Youngest suiting company | 2018 |
Some interesting questions that has been asked about the results you have just received for Bispecific Antibody
What are related technologies to Bispecific Antibody?
Based on our calculations related technologies to Bispecific Antibody are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Which industries are mostly working on Bispecific Antibody?
The most represented industries which are working in Bispecific Antibody are Biotechnology, Other, Pharmaceuticals, Medical, Healthcare
How does ensun find these Bispecific Antibody Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.
